Cargando…

Anti-dyskinetic efficacy of 5-HT3 receptor antagonist in the hemi-parkinsonian rat model

Parkinson's disease is a progressive debilitative neurodegenerative disease characterised mostly with bradykinesia, tremor, catatonia, drooping posture, unsteady gate and unstable steps. Levodopa has been proven to be among the most effective and acceptable treatment that can reconstitute dopam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aboulghasemi, Nazanin, Hadipour Jahromy, Mahsa, Ghasemi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302250/ https://www.ncbi.nlm.nih.gov/pubmed/30656239 http://dx.doi.org/10.1016/j.ibror.2018.12.001

Ejemplares similares

Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats
por: Fletcher, Edward J. R., et al.
Publicado: (2020)

The selective 5-HT(1A) receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets
por: Fisher, Ria, et al.
Publicado: (2020)

Dopamine D1 receptor signalling in dyskinetic Parkinsonian rats revealed by fiber photometry using FRET-based biosensors
por: Jones-Tabah, Jace, et al.
Publicado: (2020)

Systematic Evaluation of DBS Parameters in the Hemi-Parkinsonian Rat Model
por: Mottaghi, Soheil, et al.
Publicado: (2020)

Parkinsonian Symptoms, Not Dyskinesia, Negatively Affect Active Life Participation of Dyskinetic Patients with Parkinson’s Disease
por: Goubault, Etienne, et al.
Publicado: (2020)

Effects of Allopurinol as a xanthine oxidase inhibitor on depressive-like behavior of rats and changes in serum BDNF level
por: Jahromy, Mahsa Hadipour, et al.
Publicado: (2022)

Effects of blackberry (Morus nigra) fruit juice on levodopa-induced dyskinesia in a mice model of Parkinson’s disease
por: Fahimi, Zahra, et al.
Publicado: (2018)

Levodopa-Induced Dyskinesia Is Associated with Increased Thyrotropin Releasing Hormone in the Dorsal Striatum of Hemi-Parkinsonian Rats
por: Cantuti-Castelvetri, Ippolita, et al.
Publicado: (2010)

Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model
por: Sedaghat, Reza, et al.
Publicado: (2014)

Protective Effects of Berberis vulgaris on Diazinon-Induced Brain Damage in Young Male Mice
por: Sonei, Azadeh, et al.
Publicado: (2020)

Antidiabetic effects of the ethanolic extract of Allium saralicum R.M. Fritsch on streptozotocin‐induced diabetes in a mice model
por: Fazelipour, Simin, et al.
Publicado: (2021)

Effectiveness of Povidone-Iodine 1% Eye Drop on Streptococcus pneumoniae and Escherichia coli Induced-Keratitis in Mice
por: Hadipour Jahromy, Mahsa, et al.
Publicado: (2019)

Dopaminergic-Like Neurons Derived from Oral Mucosa Stem Cells by Developmental Cues Improve Symptoms in the Hemi-Parkinsonian Rat Model
por: Ganz, Javier, et al.
Publicado: (2014)

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats
por: Fijał, Katarzyna, et al.
Publicado: (2013)

Transplantation of Melanocytes Obtained from the Skin Ameliorates Apomorphine-Induced Abnormal Behavior in Rodent Hemi-Parkinsonian Models
por: Asanuma, Masato, et al.
Publicado: (2013)

Neuroradiological and Neurophysiological Characteristics of Patients With Dyskinetic Cerebral Palsy
por: Park, Byung-Hyun, et al.
Publicado: (2014)

Rare Form of Dyskinetic Movements Associated with Alcohol Withdrawal
por: Prakash, Sathya, et al.
Publicado: (2016)

Simultaneous Transplantation of Fetal Ventral Mesencephalic Tissue and Encapsulated Genetically Modified Cells Releasing GDNF in a Hemi-Parkinsonian Rat Model of Parkinson’s Disease
por: Perez-Bouza, Alberto, et al.
Publicado: (2017)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT(3) receptors
por: Lochner, Martin, et al.
Publicado: (2016)

The Effect of Chronic Administration of Methylphenidate on Morphometric Parameters of Testes and Fertility in Male Mice
por: Fazelipour, Simin, et al.
Publicado: (2012)

Striatal Glutamate Release in l-DOPA-Induced Dyskinetic Animals
por: Nevalainen, Nina, et al.
Publicado: (2013)

Correction: Neuroradiological and Neurophysiological Characteristics of Patients With Dyskinetic Cerebral Palsy
por: Park, Byung-Hyun, et al.
Publicado: (2015)

Functional Connectivity Alterations in Children with Spastic and Dyskinetic Cerebral Palsy
por: Qin, Yun, et al.
Publicado: (2018)

The Effect of Intrathecal Baclofen in Dyskinetic Cerebral Palsy: The IDYS Trial
por: Bonouvrié, Laura A., et al.
Publicado: (2019)

Aberrant Interhemispheric Functional Organization in Children with Dyskinetic Cerebral Palsy
por: Qin, Yun, et al.
Publicado: (2019)

Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys
por: Cuenca-Bermejo, Lorena, et al.
Publicado: (2021)

Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist.
por: Cassidy, J., et al.
Publicado: (1988)

Dual 5-HT(3) and 5-HT(6) Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats
por: Castañé, Anna, et al.
Publicado: (2022)

Early infantile epileptic-dyskinetic encephalopathy due to biallelic PIGP mutations
por: Vetro, Annalisa, et al.
Publicado: (2020)

Use of the Dyskinesia Impairment Scale in non‐ambulatory dyskinetic cerebral palsy
por: Haberfehlner, Helga, et al.
Publicado: (2019)

Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats
por: Okada, Tsuyoshi, et al.
Publicado: (2020)

An improvement in acute wound healing in rats by the synergistic effect of photobiomodulation and arginine
por: Mostafavinia, Atarodsadat, et al.
Publicado: (2019)

Role of 5-HT(2A) receptor antagonists in the treatment of insomnia
por: Vanover, Kimberly E, et al.
Publicado: (2010)

Effects of 5‐HT(₃) receptor antagonists on cisplatin‐induced kidney injury
por: Goda, Mitsuhiro, et al.
Publicado: (2021)

Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies
por: Endres, Dominique, et al.
Publicado: (2020)

Hemi-Hyperkinesis
por: Rostowski, J., et al.
Publicado: (1950)

CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
por: Capi, Matilde, et al.
Publicado: (2021)

Clinical characteristics and functional status of children with different subtypes of dyskinetic cerebral palsy
por: Sun, Dianrong, et al.
Publicado: (2018)

Instrumented assessment of motor function in dyskinetic cerebral palsy: a systematic review
por: Haberfehlner, Helga, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jvn9g8653vitp96a683jkm6tt5